Status:
UNKNOWN
Sensitivity, Threshold, Tolerance and Pain Recognition in Schizophrenia Patients and Their Relatives.
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Pain Recognition
Schizophrenia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
It has been known that schizophrenia patients have a reduced ability to recognize both their own pain and the pain of others. The patients' pain judgement is not correlated with their affective or cog...
Eligibility Criteria
Inclusion
- Patients must meet DSM-5 criteria for a diagnosis of schizophrenia.
- Patients above 18 years of age.
- Sufficient knowledge of the Hebrew language
- A stabled mental state. If hospitalized, patients are scheduled for discharge on the basis of clinical assessment of psychiatric symptoms.
Exclusion
- Mental co-morbidity.
- Peripheral neuropathies, upper limb trauma, chronic pain conditions.
- Alcohol or drug use.
- Usage of any pain reliever medications during the week before recruitment.
Key Trial Info
Start Date :
August 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05345548
Start Date
August 29 2019
End Date
January 15 2024
Last Update
April 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haemek medical center
Afula, Israel, 1910500